SavedAdd your journal

Journals / Koşuyolu Heart Journal / 2022 / Cilt: 25 - Sayı: 3

Association Between Systemic ImmuneInflammation Index and Long-Term Mortality in Patients with Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy Below the Knee

Yalçın AVCI
Mustafa DURAN
Ali Rıza DEMİR
Gökhan DEMİRCİ
Ömer TAŞBULAK
Arda GÜLER
Ahmet Arif YALÇIN
Sezgin ATMACA
Mehmet ERTÜRK
Pages
262–269
Publication Date
2022-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to our data, patients with high SII values had higher rates of mortality compared to patients with low SII values (65.2% vs 30.3%, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Endovascular interventions have been increasingly used for the treatment of patients suffering from below-the-knee (BTK) ischemic lesions.
📊
Key Findings & Data:Patients and Methods: The records of 112 patients with symptomatic CLI undergoing endovascular revascularization for BTK lesions between January 2015 and December 2019 were analyzed.
💡
Conclusion & Impact:According to our data, patients with high SII values had higher rates of mortality compared to patients with low SII values (65.2% vs 30.3%, p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Endovascular procedures · inflammation · peripheral arterial disease

Abstract

Introduction: Endovascular interventions have been increasingly used for the treatment of patients suffering from below-the-knee (BTK) ischemic lesions. Yet, there is a paucity of data regarding long-term adverse events in patients with critical limb ischemia (CLI) undergoing endovascular revascularization for BTK lesions. Recently introduced systemic immune-inflammation index (SII) is a reliable indicator of poor outcomes in various cardiovascular conditions. Herein, we aimed to investigate the prognostic role of the SII on mortality in patients with CLI undergoing endovascular revascularization for BTK lesions. Patients and Methods: The records of 112 patients with symptomatic CLI undergoing endovascular revascularization for BTK lesions between January 2015 and December 2019 were analyzed. Patients were divided into groups with low and high SII values based on an SII cut-off value derived from a ROC analysis. For each group, procedural details and follow-up outcomes were analyzed. Results: The mean follow-up time was 40.3 ± 19.9 months. According to our data, patients with high SII values had higher rates of mortality compared to patients with low SII values (65.2% vs 30.3%, p

🔖

Cite This Article

AVCI, Y., DURAN, M., DEMİR, A. R., DEMİRCİ, G., TAŞBULAK, Ö., GÜLER, A., YALÇIN, A. A., ATMACA, S., ERTÜRK, M. (2022). Association Between Systemic ImmuneInflammation Index and Long-Term Mortality in Patients with Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy Below the Knee. Koşuyolu Heart Journal, Cilt: 25 - Sayı: 3, 262–269. https://ajindex.com/articles/866281

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Davies MG. Criticial limb ischemia: Epidemiology. Methodist Debakey Cardiovasc J 2012
  2. 8(4):10-4. [Crossref] 2. Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: Current challenges and future prospects. Vasc Health Risk Manag 2018
  3. [Crossref] 3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007
  4. [Crossref] 4. Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: From 2003-2011. J Am Coll Cardiol 2016
  5. 67(16):1901-13. [Crossref] 5. Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, et al. The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes. JACC Cardiovasc Interv 2020
  6. 13(4):431-43. [Crossref] 6. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 2014
  7. 20(23):6212-22. [Crossref] 7. Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis. J Cancer 2018
  8. 9(18):3295-302. [Crossref] 8. Huang J, Zhang Q, Wang R, Ji H, Chen Y, Quan X, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monit 2019
  9. [Crossref] 9. Seo M, Yamada T, Morita T, Frukawa Y, Tamaki S, Iwasaki Y, et al. Prognostic value of systemic immune-inflammation index in patients with chronic heart failure. Eur Heart J 2018
  10. 39(1):ehy564.P589. [Crossref] 10. Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, et al. Systemic immune inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest 2020
  11. 50(5):13230. [Crossref] 11. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-theknee arteries: A supplement to the Inter-Society consensus for the management of peripheral arterial disease (TASC II). Vasc Med 2015
  12. 20(5):465-78. [Crossref] 12. Rathakrishnan B, Secemsky EA. Turning the tide: Evolution of below-the-knee endovascular intervention. Vasc Med 2021
  13. 26(1):26-7. [Crossref] 13. Peregrin JH, Koznar B, Kovác J, Lastovickov